Navigation Links
European Multiple Sclerosis Market in Dire Need of Increased Disease Awareness and Treatment Options, Cautions Frost & Sullivan
Date:3/14/2012

gnostic tools. Another issue is the absence of established treatment procedures.

"Non-compliance with MS treatment procedures remains a major challenge," explains Deepika. "Establishing end-user confidence has become difficult due to unsatisfactory therapeutic results."

Cumbersome and painful procedures discourage the progress of therapy. Simple advances, like the use of oral drugs instead of injections, will prove beneficial to promoting compliance with therapeutic regimes.

"Awareness raising through public healthcare forums and organisations about new developments and innovative treatment options will contribute toward establishing greater end-user confidence," concludes Deepika. "In the meantime, precautionary measures like adopting healthy lifestyle practices will help limit the incidence of the disease."

If you are interested in more information on this study, please send an e-mail with your contact details to Janique Morvan, Corporate Communications, at janique.morvan@frost.com.

Analysis of the European Multiple Sclerosis is part of the Pharmaceuticals & Biotechnology Growth Partnership Service programme, which also includes research in the following markets: European Biosimilars Market, Global Generics Market and European Autoimmune Diseases Therapeutics Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies.
'/>"/>

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
2. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
3. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
4. Inspiration Biopharmaceuticals Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B
5. Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress
6. Generex Makes Podium Presentation of Clinical Data on Generex Oral-lyn™ at European Association for the Study of Diabetes Annual Meeting
7. Metabolic Solutions Development Company Presents New Brown Fat Research at the European Association for the Study of Diabetes
8. European Medicines Agency Accepts Vanda Pharmaceuticals Inc.s Marketing Authorization Application For Oral Iloperidone Tablets
9. Amsterdam Molecular Therapeutics Files Glybera® European Marketing Application for Re-examination
10. Kuros Announces Allowance of European Patent for Synthetic Biomaterials
11. BioSpecifics Technologies Corp. Announces Data Presentations at Upcoming XVI Annual Federation of the European Societies for Surgery of the Hand Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Researchers from the Southern University of Denmark have ... the acne causing P.acnes bacteria. Researchers believe found that when ... oxygen deprived location to seek shelter and grow. When an ... ability to live in the open joint areas, causing inflammation ... The best acne treatment ” explains why starting a normal ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 The World ... the appointment of Lisa Baird as Executive Director. ... 8, 2013. The WMIS vision is to ... to understand and effectively treat diseases in the developed ... (WMIS) was established in 2011 by integrating the Academy ...
(Date:5/17/2013)... Oven Industries Inc. announces a new temperature ... has many user-friendly benefits. Contained all in one enclosure, ... a self-contained temperature control system, which has ... device unique, as well as highly convenient for users. ... universally, which allows the user to use the device ...
(Date:5/17/2013)... RESEARCH TRIANGLE PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability , ... drought and insect pressures , Syngenta ... grand opening celebration today at the company’s RTP Innovation ... Crop Lab allows company researchers to simulate any agricultural ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2WMIS Appoints Lisa Baird as Next Executive Director 2New Temperature Control Products Announced by Oven Industries Inc. 2Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3
... in small, medium and ... ... BSX ) today announced CE Mark approval of its ACUITY(R),Spiral ... resynchronization therapy pacemakers, both of,which treat heart failure. The product features ...
... France, March 3 NicOx S.A.,(Euronext Paris: COX) ... studies in the United States, which will assess ... ibuprofen and naproxen,using the Ambulatory Blood Pressure Monitoring ... in duration, will together recruit a,total of around ...
... March 3 BioWa, Inc. announced today,that ... Genentech, Inc. providing,Genentech additional access to BioWa,s ... select antibodies for potential therapeutic,applications that require ... is pleased to extend this license with ...
Cached Biology Technology:Boston Scientific Announces European Approval of New Heart Failure Lead 2Boston Scientific Announces European Approval of New Heart Failure Lead 3NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 2NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 3NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 4NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 5BioWa Announces Expansion of License Agreement with Genentech for BioWa's POTELLIGENT(R) Technology 2
(Date:5/17/2013)... Ill. An international team of ... structure and cell movement inside a living frog embryo ... a new method to advance biological research and the ... Northwestern University and the Karlsruher Institut fr Technologie in ... the U.S. Department of Energy,s Argonne National Laboratory, released ...
(Date:5/16/2013)... For decades, scientists have used ancient shorelines to predict the ... Markings of a high shoreline from three million years ago, ... period were thought to be evidence of a high ... This assumption has led many scientists to think that if ... they may do just the same in our modern, progressively ...
(Date:5/16/2013)... Why do so many sports players and athletes choose ... new study to be published in Psychological Science ... suggests that it may have to do with their ... scientist Daniel Farrelly of the University of Sunderland and ... color in a competitive task had higher testosterone levels ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2World's biggest ice sheets likely more stable than previously believed 2High-testosterone competitors more likely to choose red 2
... have released satellite images of vast plumes of smoke emanating ... central and western Russia. Using equipment on the European ... have analysed and released still images taken on 4, 8 ... both a true colour image and as a false colour ...
... ANN ARBOR, Mich.---University of Michigan School of Dentistry has ... may be the largest clinical study to date using genetic ... William Giannobile, professor at U-M dentistry and director of the ... Dentistry, will lead the study for U-M. "It,s ...
... a DuPont subsidiary, will lead one of 15 research ... efficiency of American homes ─ the Building America Retrofit ... U.S. Department of Energy (DOE), will receive a total ... months to deliver innovative energy efficiency strategies to the ...
Cached Biology News:Fires around Moscow: A satellite perspective 2Landmark dental school study uses genetic test to help predict gum disease 2NJIT to help lead public/private partnership to develop high-efficiency homes 2
Request Info...
Request Info...
XBP-1 (F-4)...
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
Biology Products: